Bleeding and Clotting Disorders
Protocol:CSL627_3001
Condition or Disease: Hemophilia A
Study Type: Interventional (Clinical Trial)
Status: Open for enrollment
Study Title: A Phase III Open Label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII SingleChain, CSL627) in Subjects with Severe Hemophilia A
Principal I investigator: Joseph Lasky III, MD
